These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 19952420)

  • 21. Pharmacokinetic and pharmacodynamic properties of lafutidine after postprandial oral administration in healthy subjects: comparison with famotidine.
    Ikawa K; Shimatani T; Hayato S; Morikawa N; Tazuma S
    Biol Pharm Bull; 2007 May; 30(5):1003-6. PubMed ID: 17473452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absorption, elimination, and metabolism of CS-1036, a novel α-amylase inhibitor in rats and monkeys, and the relationship between gastrointestinal distribution and suppression of glucose absorption.
    Honda T; Kaneno-Urasaki Y; Murai T; Kakuta M; Nasu H; Namba E; Koga T; Okuno A; Izumi T
    Drug Metab Dispos; 2013 Apr; 41(4):878-87. PubMed ID: 23378626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The novel proton pump inhibitor pantoprazole elevates intragastric pH for a prolonged period when administered under conditions of stimulated gastric acid secretion in the gastric fistula dog.
    Postius S; Bräuer U; Kromer W
    Life Sci; 1991; 49(14):1047-52. PubMed ID: 1832475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and disposition of CS-0777, a sphingosine 1-phosphate receptor modulator, in rats and monkeys.
    Inaba S; Ikeda T; Goto M; Tanaka H; Takahashi M; Iwabuchi H; Izumi T
    Xenobiotica; 2015; 45(12):1063-80. PubMed ID: 26084376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of different omeprazole dosing on gastric pH in non-variceal upper gastrointestinal bleeding: A randomized prospective study.
    Chwiesko A; Charkiewicz R; Niklinski J; Luczaj W; Skrzydlewska E; Milewski R; Baniukiewicz A; Wroblewski E; Rosolowski M; Dabrowski A
    J Dig Dis; 2016 Sep; 17(9):588-599. PubMed ID: 27518195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of omeprazole paste on intragastric pH in clinically ill neonatal foals.
    Javsicas LH; Sanchez LC
    Equine Vet J; 2008 Jan; 40(1):41-4. PubMed ID: 18083658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dose-independent pharmacokinetics of a new reversible proton pump inhibitor, KR-60436, after intravenous and oral administration to rats: gastrointestinal first-pass effect.
    Yu SY; Bae SK; Kim EJ; Kim YG; Kim SO; Lee DH; Lim H; Lee MG
    J Pharm Sci; 2003 Aug; 92(8):1592-603. PubMed ID: 12884246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and Acid Suppressant Efficacy of Esomeprazole after Intravenous, Oral, and Subcutaneous Administration to Healthy Beagle Dogs.
    Hwang JH; Jeong JW; Song GH; Koo TS; Seo KW
    J Vet Intern Med; 2017 May; 31(3):743-750. PubMed ID: 28407418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intragastric acidity after switching from 5-day treatment with intravenous pantoprazole 40 mg/d to 5-day treatment with oral esomeprazole 40 mg/d or pantoprazole 40 mg/d: an open-label crossover study in healthy adult volunteers.
    Miner PB; Tutuian R; Castell DO; Liu S; Sostek MB
    Clin Ther; 2006 May; 28(5):725-33. PubMed ID: 16861094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of cholestyramine on the pharmacokinetics of rosiglitazone and its metabolite, desmethylrosiglitazone, after oral and intravenous dosing of rosiglitazone: impact on oral bioavailability, absorption, and metabolic disposition in rats.
    Muzeeb S; Venkatesh P; Mullangi R; Srinivas NR
    Xenobiotica; 2006 Sep; 36(9):838-56. PubMed ID: 16971347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does nicotine administration influence intragastric acidity?
    Lindell G; Brudin L; Ohlin P; Graffner H
    Scand J Gastroenterol; 1992; 27(2):143-6. PubMed ID: 1561529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastric pH influences the appearance of double peaks in the plasma concentration-time profiles of cimetidine after oral administration in dogs.
    Mummaneni V; Amidon GL; Dressman JB
    Pharm Res; 1995 May; 12(5):780-6. PubMed ID: 7479568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intragastric pH with oral vs intravenous bolus plus infusion proton-pump inhibitor therapy in patients with bleeding ulcers.
    Laine L; Shah A; Bemanian S
    Gastroenterology; 2008 Jun; 134(7):1836-41. PubMed ID: 18423628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bravo capsule system optimizes intragastric pH monitoring over prolonged time: effects of ghrelin on gastric acid and hormone secretion in the rat.
    Rudholm T; Hellstrom PM; Theodorsson E; Campbell CA; McLean PG; Naslund E
    World J Gastroenterol; 2008 Oct; 14(40):6180-7. PubMed ID: 18985808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dose-dependent pharmacokinetics of a new reversible proton pump inhibitor, DBM-819, after intravenous and oral administration to rats: hepatic first-pass effect.
    Kim EJ; Kim SO; Lee DH; Lim H; Lee MG
    Biopharm Drug Dispos; 2001 Apr; 22(3):119-28. PubMed ID: 11745914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of gastric acid with intravenous esomeprazole and omeprazole: results of 3 studies in healthy subjects.
    Röhss K; Wilder-Smith C; Kilhamn J; Fjellman M; Lind T
    Int J Clin Pharmacol Ther; 2007 Jun; 45(6):345-54. PubMed ID: 17595892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The long-lasting effect of TU-199, a novel H+, K(+)-ATPase inhibitor, on gastric acid secretion in dogs.
    Uchiyama K; Wakatsuki D; Kakinoki B; Takeuchi Y; Araki T; Morinaka Y
    J Pharm Pharmacol; 1999 Apr; 51(4):457-64. PubMed ID: 10385219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of effect of an increased dosage of vonoprazan versus vonoprazan plus lafutidine on gastric acid inhibition and serum gastrin.
    Suzuki T; Kagami T; Uotani T; Yamade M; Hamaya Y; Iwaizumi M; Osawa S; Sugimoto K; Miyajima H; Furuta T
    Eur J Clin Pharmacol; 2018 Jan; 74(1):45-52. PubMed ID: 28986609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma famotidine concentration versus intragastric pH in patients with upper gastrointestinal bleeding and in healthy subjects.
    Echizen H; Shoda R; Umeda N; Ishizaki T
    Clin Pharmacol Ther; 1988 Dec; 44(6):690-8. PubMed ID: 2904311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of species difference in peripheral lymphocyte reduction effect of CS-0777, a sphingosine 1-phosphate receptor modulator, based on a pharmacokinetic/pharmacodynamic model analysis.
    Inaba SI; Goto M; Tanaka-Takanaka K; Tanaka H; Tomisato W; Yuita H; Doi-Komuro H; Inoue R; Oshima K; Kagari T; Shimozato T; Izumi T
    Biopharm Drug Dispos; 2016 Dec; 37(9):561-573. PubMed ID: 27764535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.